Showing results (51-60 of 192) with videos related to

Sort By:
Pageof 20
Leukemia Research|January 9, 2008
Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)Yukiyasu Ozawa, Ann H Williams, Myka L Estes, et al.
American Journal of Hematology|November 17, 2010
Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Christine O'Keefe, Alan F List, et al.
Leukemia Research|December 3, 2014
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendationsValeria Santini, Thomas Prebet, Pierre Fenaux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2006
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromesGary J Schiller, James Slack, John D Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromesMikkael A Sekeres, Jaroslaw P Maciejewski, Aristotle A N Giagounidis, et al.
British Journal of Haematology|June 25, 2013
Phase I clinical trial of oral rigosertib in patients with myelodysplastic syndromesRami S Komrokji, Azra Raza, Jeffrey E Lancet, et al.
American Journal of Hematology|November 4, 2018
Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patientsAndrew T Kuykendall, Chetasi Talati, Eric Padron, et al.
Plos One|April 18, 2012
Erythropoietin receptor signaling is membrane raft dependentKathy L McGraw, Gwenny M Fuhler, Joseph O Johnson, et al.
Pageof 20